• Title of article

    Carboxylated calixarenes bind strongly to CD69 and protect CD69+ killer cells from suicidal cell death induced by tumor cell surface ligands Original Research Article

  • Author/Authors

    Karel Bezou?ka، نويسنده , , Renata ?najdrov?، نويسنده , , Karel K?enek، نويسنده , , Markéta Van?urov?، نويسنده , , Alan K?dek، نويسنده , , David Ad?mek، نويسنده , , Pavel Lhot?k، نويسنده , , Daniel Kavan، نويسنده , , Kate?ina Hofbauerov?، نويسنده , , Petr Man، نويسنده , , Pavla Bojarov?، نويسنده , , Vladimir Kren، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2010
  • Pages
    7
  • From page
    1434
  • To page
    1440
  • Abstract
    We have recently identified a new class of high affinity ligands for CD69 leukocyte membrane receptor, carboxylated calixarenes. Of the three compounds investigated here, thiacalix[4]arene had the highest affinity for CD69 in direct binding assays, and proved to be the most specific inhibitor of CD69 identified so far in receptor precipitation and cellular activation experiments. Carboxylated calixarenes also proved effective at protection of CD69high lymphocytes from apoptosis triggered by a multivalent ligand or antibody. Thus, carboxylated calixarenes set a new paradigm for noncarbohydrate ligands for CD69 making them attractive for protection of killer cells in combined animal tumor therapies.
  • Keywords
    Lymphocyte activation , Receptor cross-linking , apoptosis , Carboxylated calixarenes
  • Journal title
    Bioorganic and Medicinal Chemistry
  • Serial Year
    2010
  • Journal title
    Bioorganic and Medicinal Chemistry
  • Record number

    1307145